157 related articles for article (PubMed ID: 27193446)
21. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
[TBL] [Abstract][Full Text] [Related]
22. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes.
Stefan CP; Koehler JW; Minogue TD
Sci Rep; 2016 May; 6():25904. PubMed ID: 27174456
[TBL] [Abstract][Full Text] [Related]
23. A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.
Wilson KD; Shen P; Fung E; Karakikes I; Zhang A; InanlooRahatloo K; Odegaard J; Sallam K; Davis RW; Lui GK; Ashley EA; Scharfe C; Wu JC
Circ Res; 2015 Sep; 117(7):603-11. PubMed ID: 26265630
[TBL] [Abstract][Full Text] [Related]
24. Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases.
Liu Y; Wei X; Kong X; Guo X; Sun Y; Man J; Du L; Zhu H; Qu Z; Tian P; Mao B; Yang Y
PLoS One; 2015; 10(8):e0133636. PubMed ID: 26274329
[TBL] [Abstract][Full Text] [Related]
25. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
[TBL] [Abstract][Full Text] [Related]
26. [Detection of pathogenic mutations for methylmalonic acidemia using new-generation semiconductor targeted sequencing].
Sun Y; Jiang T; Ma D; Yang G; Yang B; Wang Y; Xu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):56-9. PubMed ID: 25636100
[TBL] [Abstract][Full Text] [Related]
27. The Next Generation of Molecular Pathology is Here: Validation of Next-Generation Sequencing Technology for Clinical Molecular Testing Across Multiple Different Disciplines.
Weck KE
Arch Pathol Lab Med; 2017 Jun; 141(6):749-750. PubMed ID: 28557596
[No Abstract] [Full Text] [Related]
28. Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Deeb KK; Hohman CM; Risch NF; Metzger DJ; Starostik P
Arch Pathol Lab Med; 2015 Jul; 139(7):913-21. PubMed ID: 26125431
[TBL] [Abstract][Full Text] [Related]
29. Nuclease-Assisted, Multiplexed Minor-Allele Enrichment: Application in Liquid Biopsy of Cancer.
Yu F; Leong KW; Makrigiorgos GM
Methods Mol Biol; 2022; 2394():433-451. PubMed ID: 35094339
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis.
Latham GJ
Expert Rev Mol Diagn; 2013 Nov; 13(8):769-72. PubMed ID: 24117229
[No Abstract] [Full Text] [Related]
31. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
32. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.
Ballester LY; Luthra R; Kanagal-Shamanna R; Singh RR
Expert Rev Mol Diagn; 2016; 16(3):357-72. PubMed ID: 26680590
[TBL] [Abstract][Full Text] [Related]
33. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
Schenk D; Song G; Ke Y; Wang Z
PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
[TBL] [Abstract][Full Text] [Related]
34. A Microfluidics Workflow for Sample Preparation for Next-Generation DNA Sequencing.
Snider A; Nilsson M; Dupal M; Toloue M; Tripathi A
SLAS Technol; 2019 Apr; 24(2):196-208. PubMed ID: 30142015
[TBL] [Abstract][Full Text] [Related]
35. Enrichment of target sequences for next-generation sequencing applications in research and diagnostics.
Altmüller J; Budde BS; Nürnberg P
Biol Chem; 2014 Feb; 395(2):231-7. PubMed ID: 24013102
[TBL] [Abstract][Full Text] [Related]
36. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
[TBL] [Abstract][Full Text] [Related]
38. Clinical mutation assay of tumors: new developments.
Starostik P
Anticancer Drugs; 2017 Jan; 28(1):1-10. PubMed ID: 27575332
[TBL] [Abstract][Full Text] [Related]
39. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
[TBL] [Abstract][Full Text] [Related]
40. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
